| Site-specific labeling of enveloped viruses with quantum dots for single virus tracking KI Joo, Y Lei, CL Lee, J Lo, J Xie, SF Hamm-Alvarez, P Wang ACS nano 2 (8), 1553-1562, 2008 | 142 | 2008 |
| Crosslinked multilamellar liposomes for controlled delivery of anticancer drugs KI Joo, L Xiao, S Liu, Y Liu, CL Lee, PS Conti, MK Wong, Z Li, P Wang Biomaterials 34 (12), 3098-3109, 2013 | 118 | 2013 |
| Enhanced real-time monitoring of adeno-associated virus trafficking by virus-quantum dot conjugates KI Joo, Y Fang, Y Liu, L Xiao, Z Gu, A Tai, CL Lee, Y Tang, P Wang ACS nano, 2011 | 105 | 2011 |
| Site‐specific modification of adeno‐associated viruses via a genetically engineered aldehyde tag Y Liu, Y Fang, Y Zhou, E Zandi, CL Lee, KI Joo, P Wang Small 9 (3), 421-429, 2013 | 58 | 2013 |
| Gene editing of human embryonic stem cells via an engineered baculoviral vector carrying zinc-finger nucleases Y Lei, CL Lee, KI Joo, J Zarzar, Y Liu, B Dai, V Fox, P Wang Molecular therapy 19 (5), 942-950, 2011 | 46 | 2011 |
| Imaging multiple intermediates of single‐virus membrane fusion mediated by distinct fusion proteins KI Joo, A Tai, CL Lee, C Wong, P Wang Microscopy research and technique 73 (9), 886-900, 2010 | 19 | 2010 |
| Construction of stable producer cells to make high‐titer lentiviral vectors for dendritic cell‐based vaccination CL Lee, M Chou, B Dai, L Xiao, P Wang Biotechnology and Bioengineering 109 (6), 1551-1560, 2012 | 13 | 2012 |
| Engineered lentiviral vectors pseudotyped with a CD4 receptor and a fusogenic protein can target cells expressing HIV-1 envelope proteins CL Lee, J Dang, KI Joo, P Wang Virus research 160 (1-2), 340-350, 2011 | 13 | 2011 |
| Alteration of select gene expression patterns in individuals infected with HIV‐1 E Serrao, CH Wang, T Frederick, CL Lee, P Anthony, D Arribas‐Layton, ... Journal of medical virology 86 (4), 678-686, 2014 | 9 | 2014 |
| A tetracycline-regulated cell line produces high-titer lentiviral vectors that specifically target dendritic cells PD Bryson, C Zhang, CL Lee, P Wang JoVE (Journal of Visualized Experiments), e50606, 2013 | 5 | 2013 |
| Bio-production of lentiviral vectors CL Lee, JS Bartlett US Patent 10,138,495, 2018 | 3 | 2018 |
| Mutagenesis of the E1 Domain of Sindbis Virus Glycoprotein Alters its pH-Dependent Fusion CL Lee, Y Liu, J Dang, KI Joo, P Wang Nano Life 4 (03), 1441002, 2014 | | 2014 |
| テトラサイクリン調節細胞株は, 具体的に樹状細胞を標的とする高力価レンチウイルスベクターを生成 PD Bryson, C Zhang, CL Lee, P Wang | | 2013 |
| Engineering lentiviral vectors for gene therapy and DC-vaccine CL Lee University of Southern California, 2012 | | 2012 |
| 387. Engineered Lentiviral Vectors Pseudotyped with a CD4 Receptor and a Fusogenic Protein Can Target Cells Expressing HIV-1 Envelope Proteins CL Lee, J Dang, KI Joo, P Wang Molecular Therapy 19, 1, 2011 | | 2011 |
| Stable Packaging Cell lines for Production of Human immunodeficiency virus type 1 vector with engineered Sindbis virus glycoprotein CL Lee, P Wang | | |
Pin WangUniversity of Southern California, Professor of Chemical Engineering, Biomedical EngineeringVerified email at usc.edu
